Last edition
News about "Phase 3 pivotal trial"
Milestone Pharmaceuticals Enrolls First Patient in Phase 3 Trial of Etripamil for AFib-RVR
Milestone Pharmaceuticals has begun its Phase 3 ReVeRA-301 trial to evaluate self-administered etripamil nasal spray for acute AFib-RVR, targeting rapid ventricular rate reduction and symptom relief.
Phase 3 Pivotal Trial | 24/08/2026 | By News Bureau
OKYO Pharma Receives FDA Support to Advance Urcosimod into Global Phase 3 Trial
Positive feedback from the US FDA has reinforced OKYO Pharma's clinical development strategy for urcosimod, with the company preparing to launch a global Phase 3 trial for neuropathic corneal pain, a debilitating eye disorder that currently lacks FDA-approved therapies.
Phase 3 Pivotal Trial | 13/07/2026 | By News Bureau | 114
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy